Imatinib induces c-kit positive myeloma cells apoptosis / 中华血液学杂志
Chinese Journal of Hematology
;
(12): 230-233, 2008.
Article
Dans Chinois
| WPRIM
| ID: wpr-240033
ABSTRACT
<p><b>OBJECTIVE</b>To explore the influence of Imatinib on multiple myeloma cells expressing c-kit in vitro and its mechanism.</p><p><b>METHODS</b>KM3 cells were treated with Imatinib at different concentrations, and cell growth index were evaluated by XTT assay, cell cycle by flow cytometry, apoptosis by Annexin V/ PI and DNA ladder, and change in protein level by Western blot.</p><p><b>RESULTS</b>Imatinib inhibited proliferation of KM3 cells at concentrations more than 0.25 micromol/L in a dose-dependent manner, and the 48 h IC50 was 0.33 micromol/L (P < 0.01). Imatinib arrested cell in C0/G1 phase. Annexin V/PI staining and DNA ladder indicated that Imatinib had a substantial effect on inducing apoptosis of KM3 cells in a dose-dependent manner and induced pro-caspase-3 and poly ADP-ribose polymerase (PARP) cleaved. Imatinib inhibited expression of c-kit and provoked a decrease of IL-6 induced c-kit phosphorylation in vitro.</p><p><b>CONCLUSION</b>Imatinib inhibits KM3 cells proliferation and induces the cells apoptosis by inhibiting c-kit signalling transduction.</p>
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Anatomopathologie
/
Pharmacologie
/
Pipérazines
/
Pyrimidines
/
Benzamides
/
Cycle cellulaire
/
Différenciation cellulaire
/
Apoptose
/
Protéines proto-oncogènes c-kit
/
Lignée cellulaire tumorale
Limites du sujet:
Humains
langue:
Chinois
Texte intégral:
Chinese Journal of Hematology
Année:
2008
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS